Pain Prevalence and Risk Factors Among Sarcoma/Melanoma Oncology Patients in an Outpatients Setting
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01034696|
Recruitment Status : Completed
First Posted : December 17, 2009
Last Update Posted : May 23, 2016
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||250 participants|
|Official Title:||Pain Prevalence and Risk Factors Amongst Sarcoma/Melanoma Oncology Outpatients. A Baseline, Cross Sectional Study Towards a Pain Free Hospital|
|Study Start Date :||May 2009|
|Actual Primary Completion Date :||January 2010|
|Actual Study Completion Date :||January 2010|
- The proportion of patients with significant pain and the proportion of patients with a negative score on the pain management index (PMI)
- Proportion of patients with neuropathic pain.
- Potential predictors of pain. The variables tested as potential risk factors will be age, tumour type, gender and treatment type.
- We will also seek to identify potential predictors of pain intensity in patients that do have pain. In addition to the risk factors already mentioned above, duration and cause of pain will also be tested in this case as potential pain predictors.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01034696
|Royal Marsden Hospital|
|Sutton, Surrey, United Kingdom, SM25PT|
|Principal Investigator:||Dr John Williams||Royal Marsden NHS Foundation Trust|